These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 10435781

  • 1. Effects of mu and kappa opioid receptor antagonists on glucoprivic induction of Fos immunoreactivity in the rat preoptic area and hypothalamus.
    Briski KP, Teodecki L.
    Brain Res Bull; 1999 Jun; 49(3):181-7. PubMed ID: 10435781
    [Abstract] [Full Text] [Related]

  • 2. Co-distribution of Fos- and mu opioid receptor immunoreactivity within the rat septopreoptic area and hypothalamus during acute glucose deprivation: effects of the mu receptor antagonist CTOP.
    Briski KP, Sylvester PW.
    Neurosci Lett; 2001 Jun 29; 306(3):141-4. PubMed ID: 11406315
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Alterations in deprivation, glucoprivic and sucrose intake following general, mu and kappa opioid antagonists in the hypothalamic paraventricular nucleus of rats.
    Koch JE, Glass MJ, Cooper ML, Bodnar RJ.
    Neuroscience; 1995 Jun 29; 66(4):951-7. PubMed ID: 7651622
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of mu and kappa opioid antagonists on Fos-like immunoreactivity in extended amygdala.
    Carr KD, Kutchukhidze N, Park TH.
    Brain Res; 1999 Mar 20; 822(1-2):34-42. PubMed ID: 10082881
    [Abstract] [Full Text] [Related]

  • 6. Induction of immediate-early gene expression in preoptic and hypothalamic neurons by the glucocorticoid receptor agonist, dexamethasone.
    Briski KP, DiPasquale BM, Gillen E.
    Brain Res; 1997 Sep 12; 768(1-2):185-96. PubMed ID: 9369315
    [Abstract] [Full Text] [Related]

  • 7. CRF alters the infundibular LHRH secretory system from the medial preoptic area of female rats: possible involvement of opioid receptors.
    Rivest S, Plotsky PM, Rivier C.
    Neuroendocrinology; 1993 Sep 12; 57(2):236-46. PubMed ID: 8389996
    [Abstract] [Full Text] [Related]

  • 8. Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus.
    Laorden ML, Castells MT, Martínez MD, Martínez PJ, Milanés MV.
    Endocrinology; 2000 Apr 12; 141(4):1366-76. PubMed ID: 10746640
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intraventricular 2-deoxy-D-glucose induces Fos expression by hypothalamic vasopressin, but not oxytocin neurons.
    Briski KP.
    Brain Res Bull; 2000 Feb 12; 51(3):275-80. PubMed ID: 10718520
    [Abstract] [Full Text] [Related]

  • 11. Glucoprivic induction of Fos immunoreactivity in hypothalamic dopaminergic neurons.
    Briski KP.
    Neuroreport; 1998 Jan 26; 9(2):289-95. PubMed ID: 9507971
    [Abstract] [Full Text] [Related]

  • 12. Central opioid receptors mediate glucoprivic inhibition of pituitary LH secretion.
    Briski KP.
    Am J Physiol; 1997 Apr 26; 272(4 Pt 1):E517-22. PubMed ID: 9142869
    [Abstract] [Full Text] [Related]

  • 13. Opioidergic projections to sleep-active neurons in the ventrolateral preoptic nucleus.
    Greco MA, Fuller PM, Jhou TC, Martin-Schild S, Zadina JE, Hu Z, Shiromani P, Lu J.
    Brain Res; 2008 Dec 15; 1245():96-107. PubMed ID: 18840417
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of opioid receptor subtype antagonist effects in the ventral tegmental area upon food intake under deprivation, glucoprivic and palatable conditions.
    Ragnauth A, Ruegg H, Bodnar RJ.
    Brain Res; 1997 Aug 29; 767(1):8-16. PubMed ID: 9365010
    [Abstract] [Full Text] [Related]

  • 15. Expression of Fos-like proteins in the preoptic area and hypothalamus of the rat brain following intracerebral or peripheral administration of colchicine.
    Gillen E, Briski KP.
    Neurochem Res; 1997 May 29; 22(5):549-54. PubMed ID: 9131632
    [Abstract] [Full Text] [Related]

  • 16. General, mu and kappa opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditions.
    Bodnar RJ, Glass MJ, Ragnauth A, Cooper ML.
    Brain Res; 1995 Nov 27; 700(1-2):205-12. PubMed ID: 8624711
    [Abstract] [Full Text] [Related]

  • 17. Septopreoptic mu opioid receptor mediation of hindbrain glucoprivic inhibition of reproductive neuroendocrine function in the female rat.
    Singh SR, Briski KP.
    Endocrinology; 2004 Nov 27; 145(11):5322-31. PubMed ID: 15308614
    [Abstract] [Full Text] [Related]

  • 18. Hypothalamic orexin-A-immunpositive neurons express Fos in response to central glucopenia.
    Briski KP, Sylvester PW.
    Neuroreport; 2001 Mar 05; 12(3):531-4. PubMed ID: 11234758
    [Abstract] [Full Text] [Related]

  • 19. Reduction by central beta-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions.
    Arjune D, Standifer KM, Pasternak GW, Bodnar RJ.
    Brain Res; 1990 Dec 03; 535(1):101-9. PubMed ID: 1963340
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of tuberoinfundibular dopaminergic neural activity during suckling: involvement of mu and kappa opiate receptor subtypes.
    Callahan P, Baumann MH, Rabii J.
    J Neuroendocrinol; 1996 Oct 03; 8(10):771-6. PubMed ID: 8910807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.